Chylothorax – Causes, Symptoms and Treatment
Chylothorax is an accumulation of lymphatic fluid (chyle) in the chest cavity. It is usually caused by injury or disease affecting the thoracic duct and requires prompt medical attention.
Things worth knowing about "Chylothorax"
Chylothorax is an accumulation of lymphatic fluid (chyle) in the chest cavity. It is usually caused by injury or disease affecting the thoracic duct and requires prompt medical attention.
What Is Chylothorax?
Chylothorax is a condition in which chyle – a milky-white lymphatic fluid rich in fats and lymphocytes – accumulates in the pleural space, the area between the lungs and the chest wall. Chyle originates from the thoracic duct, the largest lymphatic vessel in the body, which carries lymph from the digestive system and lower body parts. Chylothorax is a rare but potentially serious condition that requires careful diagnosis and targeted treatment.
Causes
The causes of chylothorax are broadly divided into two categories:
Traumatic Chylothorax
- Thoracic surgery (e.g., cardiac surgery, esophageal surgery, lung resection) is the most common cause
- Blunt or penetrating chest trauma
- Neck procedures or central venous catheter placement causing vessel injury
Non-Traumatic Chylothorax
- Malignancies, especially lymphomas (e.g., Hodgkin lymphoma, non-Hodgkin lymphoma) that compress or invade the thoracic duct
- Inflammatory conditions such as sarcoidosis or tuberculosis
- Lymphangiomatosis and congenital malformations of the lymphatic system
- Liver cirrhosis and other conditions causing elevated lymphatic flow
- Idiopathic chylothorax (no identifiable cause)
Symptoms
Symptoms depend on the volume of accumulated fluid and the rate at which it collects:
- Dyspnea (shortness of breath), often the first symptom to appear
- Cough and chest tightness
- Reduced breath sounds on the affected side
- Tachycardia (rapid heart rate)
- Malnutrition and immune suppression in persistent chylothorax, due to ongoing loss of fats, proteins, and lymphocytes
- Weight loss and general weakness in chronic cases
Diagnosis
Diagnosis is established through a combination of the following investigations:
- Imaging: Chest X-ray or CT scan to detect the pleural effusion
- Thoracentesis (pleural tap): Aspiration of pleural fluid for analysis – chyle appears milky-white and shows elevated triglyceride levels (>110 mg/dl) with a predominance of lymphocytes
- Lymphoscintigraphy or lymphangiography: To localize the site of lymphatic leakage
- MRI or PET-CT to identify underlying malignancy if suspected
Treatment
Treatment depends on the underlying cause and the severity of the condition:
Conservative Management
- Dietary modification: A low-fat diet supplemented with medium-chain triglycerides (MCT fats), which are absorbed directly via the portal vein rather than the lymphatic system, thereby reducing lymph flow
- Total parenteral nutrition (TPN): Complete intravenous nutrition to give the thoracic duct full rest
- Medications: Somatostatin or its analogue octreotide to reduce lymphatic flow
- Pleural drainage via chest tube to relieve fluid accumulation
Surgical and Interventional Treatment
- Thoracic duct ligation: Surgical closure of the lymphatic vessel, typically performed via video-assisted thoracoscopic surgery (VATS)
- Pleurodesis: Chemical or mechanical adhesion of the pleural layers to prevent further fluid accumulation
- Lymphatic embolization: An interventional radiology procedure to seal the point of leakage
Treatment of the Underlying Condition
In malignant chylothorax, treating the underlying tumor with chemotherapy or radiation therapy is the primary approach.
Complications
Untreated or prolonged chylothorax can lead to serious complications including malnutrition, immunodeficiency due to lymphocyte loss, electrolyte imbalances, and respiratory failure. Early diagnosis and prompt treatment are therefore essential.
References
- McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respiratory Medicine. 2010;104(1):1-8.
- Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. European Journal of Cardio-Thoracic Surgery. 2007;32(2):362-369.
- Doerr CH, Allen MS, Nichols FC, Ryu JH. Etiology of chylothorax in 203 patients. Mayo Clinic Proceedings. 2005;80(7):867-870.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Chylothorax-en